The survival time of cancer patients is connected with immunogenicity, and immunological responses have a considerable effect on the clinical outcomes of patients.51 We evaluated the correlation of three independent prognostic FOX genes (FOXD4, FOXH1, and FOXS1) with tumor immunity in COAD (Figure 6). This evidence concerns the gene FOXH1 and neoplasm.